Sector portfolio · VC firm · United States
Decheng Capital's Biotech portfolio
Decheng Capital has backed 12 Biotech startups in rounds we track, $1.0B between them, shown by the stage each has reached. The best-funded is Arcus Biosciences.
Funding by segment
- Series A$251M5
- Series B$135M3
- Stage not reported$70M2
- Series C and later$563M2
Where they are based
- United States8$803M
- China3$75M
- United Kingdom1$140M
United States
China
United KingdomFounded
5 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M6
- $50M to $250M5
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
7 of 12 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States8
- China3
- United Kingdom1
Startups by country, 3 countries in all.
Segment by segment
Series A
5 startups · $251M raised
Ottimo PharmaOttimo Pharma is a private, clinical-stage biotechnology company based in Sandwich, Kent, United Kingdom.United Kingdom$140M- VVelosBioVelosBio is a next-generation oncology company, developing novel antibody-drug conjugates to treat haematological cancers.United States$58M
- ABAadi BiosciencesUnited States$23M
- BBBaoyuan BiomedicalChina$15M
- AAnHeartChina$15M
Series B
3 startups · $135M raised
OmniomeOmniome engages in developing a proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy.United States$60M
ReadCoorLeader in true multi-omic spatial sequencingUnited States$50M
GeneWEAVEAdvancing clinical microbiology with sample-in/susceptibility-out diagnostic solutionsUnited States$25M
Stage not reported
2 startups · $70M raised
- KPKeChow PharmaKeChow Pharma, Inc.China$45M
- MCMynosys Cellular DevicesUnited States$25M
Series C and later
2 startups · $563M raised
Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
GenapsysGenapSys is a California-based biotechnology company that develops and commercializes genome DNA sequencing, CMOS detectors, and rUnited States$136M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Decheng Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Decheng Capital?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.